Edang, Fajurie .

HRN: 23-16-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2023
CEFUROXIME 1.5GM (VIAL)
06/22/2023
06/23/2023
IV
1.5gm 6 Doses
Q8
SP CS
Waiting Final Action 
06/22/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/22/2023
06/28/2023
IV
500mg 6 Doses
Q8
SP CS
Waiting Final Action 
06/24/2023
CEFUROXIME 500MG (TAB)
06/24/2023
06/29/2023
PO
500mg
BID X 5 More Days
S/P CS; Thickly MSAF
Waiting Final Action 
06/24/2023
METRONIDAZOLE 500MG (TAB)
06/24/2023
06/29/2023
PO
500mg
TID X 5 More Days
S/P CS; Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: